Citation:Gittelman MC, Hertzman B, Bailen J, Williams T, Koziol I, Henderson RJ, et al 2013
From Cancer Guidelines Wiki
Citation
Gittelman MC, Hertzman B, Bailen J, Williams T, Koziol I, Henderson RJ, et al. PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study. J Urol 2013 Jul;190(1):64-9 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23416644.
Critical appraisals
Compare quality appraisals for each clinical question
- [[Clinical question:In men who have been referred with suspected prostate cancer, what are the prognostic factors that determine the need for further investigation following a prior negative biopsy?|Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:In men who have been referred with suspected prostate cancer, what are the prognostic factors that determine the need for further investigation following a prior negative biopsy?</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:In men who have been referred with suspected prostate cancer, what are the prognostic factors that determine the need for further investigation following a prior negative biopsy?|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:In men who have been referred with suspected prostate cancer, what are the prognostic factors that determine the need for further investigation following a prior negative biopsy?</span></span></span></span>»]] (compare critical appraisals)